Given that high level of BIRC5 conferred shorter survival in breast cancer patients, we then sought to investigate whether BIRC5 and potential chemical drugs could modulate each other using the Comparative Toxicogenomics Database. The gene discussed is BIRC5; the disease is breast cancer.